Imago BioSciences Inc. (IMGO)
NASDAQ: IMGO
· Real-Time Price · USD
36.01
0.00 (0.00%)
At close: Jan 10, 2023, 10:00 PM
Company Description
Imago BioSciences, Inc., a clinical stage biopharmaceutical company, discovers and develops small molecule product candidates that target lysine-specific demethylase 1(LSD1), an enzyme that used in the production of blood cells in the bone marrow.
Its lead product candidate is bomedemstat, which is in Phase II clinical trials for the treatment of myeloproliferative neoplasms chronic cancers of the bone marrow, such as myelofibrosis, essential thrombocythemia, and polycythemia vera.
The company was incorporated in 2012 and is headquartered in South San Francisco, California.
Imago BioSciences Inc.
| Country | United States |
| IPO Date | Jul 16, 2021 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 41 |
| CEO | Hugh Young Rienhoff Jr., |
Contact Details
Address: 329 Oyster Point Boulevard South San Francisco, California United States | |
| Website | https://www.imagobio.com |
Stock Details
| Ticker Symbol | IMGO |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001623715 |
| CUSIP Number | 45250K107 |
| ISIN Number | US45250K1079 |
| Employer ID | 45-4915810 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Dr. Hugh Young Rienhoff Jr., M.D. | Chief Executive Officer & Director |
| Laura G. Eichorn | Chief Financial Officer |
| Dr. Amy E. Tapper Ph.D. | Chief of Technical Operations |
| Hsiangyi Chiang | Senior Vice President of Fin. & Principal Accounting Officer |
| Jennifer Peppe | Global Head of Clinical Operations |
| Michael H. Arenberg J.D., M.B.A. | Chief Operating & Bus. Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Feb 14, 2023 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Feb 01, 2023 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Jan 26, 2023 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Jan 23, 2023 | 15-12G | Filing |
| Jan 20, 2023 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Jan 12, 2023 | SC 13D/A | [Amend] Filing |
| Jan 11, 2023 | 4 | Filing |
| Jan 11, 2023 | 4 | Filing |
| Jan 11, 2023 | 4 | Filing |
| Jan 11, 2023 | 4 | Filing |